The first preclinical abstract on ATG-O42 (MTAPnull-selective small molecule PRMT5 inhibitor) as well as the latest data on the proprietary T cell engager platform, AnTenGagerTM, and ATG-102 (LILRB4 x CD3 T cell engager). The first view of ATG-022 (Claudin 18.2 ADC) companion diagnostic….

SAN FRANCISCO, March 5, 2024 /PRNewswire/ — Wells Fargo Bank, N.A., (“Wells Fargo”) has filed a legal motion seeking more time to rebut three (3) expert reports submitted by the Plaintiffs in a nationwide class action lawsuit alleging racial discrimination in the bank’s mortgage lending…

NEW YORK, March 5, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) between November 11, 2022 and November 8, 2023, both dates inclusive (the “Class Period”), of the important April…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.